CSTA Human, His

Cystatin A Human Recombinant, His tag
Shipped with Ice Packs
In Stock

Description

Biological Functions and Mechanisms

CSTA (Cystatin A) is a stefin-family protein that inhibits cysteine proteases like cathepsins B, H, and L, which are implicated in extracellular matrix remodeling and inflammatory responses . Recent findings highlight its roles in:

Epithelial Barrier Integrity

  • CSTA maintains tight junctions in epithelial cells. Knockdown experiments in HaCaT keratinocytes revealed enlarged intercellular gaps and reduced adhesion proteins (e.g., CDH1, ZO-1) .

  • In esophageal strictures, diminished CSTA expression correlates with dysfunctional epithelial barriers .

Psoriasis Susceptibility

  • Genetic studies link the CSTA TCC haplotype (-190T/+162C/+344C) to psoriasis (OR = 3.45, P < 0.001). This risk is amplified in carriers of the HLA-Cw6 allele (OR = 2.22, P = 0.0004) .

  • CSTA overexpression in psoriatic skin suggests its role in dysregulated protease activity and inflammation .

Research Applications

CSTA Human, His is utilized in studies spanning cancer, dermatology, and immunology (Table 2).

Table 2: Key Research Areas

ApplicationFindings
Cancer BiomarkerOverexpressed in squamous cell carcinomas; potential diagnostic marker .
Drug DevelopmentUsed to screen inhibitors targeting cysteine proteases in metastasis .
Inflammatory ModelsProtects keratinocytes from inflammation-induced apoptosis .

Handling and Stability

  • Storage: ≤-20°C in 20 mM Tris-HCl (pH 8.0) with 10% glycerol .

  • Reconstitution: Avoid freeze-thaw cycles; add carrier protein (0.1% HSA/BSA) for long-term storage .

  • Endotoxin Levels: <1.0 EU/μg, ensuring suitability for cell culture .

Future Directions

Ongoing research explores CSTA’s therapeutic potential in:

  • Esophageal Repair: Enhancing epithelial barrier function in strictures .

  • Autoimmune Therapies: Targeting CSTA-protease interactions in psoriasis .

Product Specs

Introduction
Cystatin-A, an intracellular inhibitor of cysteine proteinase cathepsin B (CatB), belongs to the cystatin superfamily's family 1. As a stefin, CSTA inhibits cysteine proteases, forming tight complexes with papain and cathepsins B, H, and L. It is suggested that extracellular CatB, along with other proteinases, undergoes a cascade-like activation process. Both CatB and its inhibitor, Cystatin-A, play crucial roles in degrading extracellular matrix proteins during tissue remodeling. In keratinocytes, CSTA acts as a precursor protein of the cornified cell envelope, contributing to epidermal development and maintenance. High concentrations of Cystatin-A have been observed in epithelial cells, polymorphonuclear leukocytes, and lymphoid tissue. Stefins show potential as prognostic and diagnostic tools in cancer.
Description
Produced in E. coli, CSTA is a single, non-glycosylated polypeptide chain consisting of 118 amino acids (with the active protein encompassing amino acids 1-98). Its molecular mass is 13.1kDa. The CSTA protein includes a 20 amino acid His-tag fused to the N-terminus and undergoes purification using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered clear solution
Formulation
Cystatin-A is provided at a concentration of 1mg/ml in a buffer solution containing 20mM Tris-HCl (pH 8.0), 1mM DTT, and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), store at 4°C. For longer storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Synonyms
Cystatin-A, Cystatin-AS, Stefin-A, CSTA, STF1, STFA.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MIPGGLSEAK PATPEIQEIV DKVKPQLEEK TNETYGKLEA VQYKTQVVAG TNYYIKVRAG DNKYMHLKVF KSLPGQNEDL VLTGYQVDKN KDDELTGF.

Q&A

What is Cystatin A (CSTA) and what are its primary biological functions?

Cystatin A (CSTA), also known as Stefin-A, STF1, or STFA, is an intracellular thiol protease inhibitor that plays critical roles in several biological processes. The protein is particularly important for desmosome-mediated intercellular adhesion, especially in the epidermis .

CSTA functions primarily as a regulator of cellular proteolytic activity, inhibiting cysteine proteases to maintain appropriate proteolytic balance within cells. This inhibitory function is essential for various physiological processes including:

  • Regulation of protein turnover

  • Cell adhesion maintenance in epithelial tissues

  • Protection against inappropriate protease activity

  • Contributing to signaling transduction pathways

The protein is associated with research areas including cancer and signal transduction pathways , suggesting broader regulatory roles beyond simple protease inhibition.

PropertyValueReference
Molecular Weight13.1-14.0 kDa
Length (native)98 amino acids
Length (His-tagged)118 amino acids
UniProt IDP01040
Entrez Gene1475
Known synonymsCystatin-A, Cystatin-AS, Stefin-A, CSTA, STF1, STFA

What is the significance of the His-tag in recombinant CSTA protein research?

The His-tag (typically six consecutive histidine residues) in recombinant CSTA serves several important research purposes:

  • Purification efficiency: The His-tag allows for one-step affinity chromatography purification using metal chelate resins, enabling researchers to obtain highly pure protein preparations (>95% as verified by SDS-PAGE) .

  • Detection capabilities: The tag provides an epitope for antibody recognition, facilitating western blotting and immunodetection without requiring CSTA-specific antibodies.

  • Standardization: Commercial recombinant CSTA proteins with His-tags ensure experimental consistency across different research groups.

What are the recommended storage and handling conditions for recombinant CSTA?

Based on manufacturer recommendations, recombinant CSTA should be stored under the following conditions to maintain stability and biological activity:

Storage ParameterRecommended ConditionReference
Temperature-60°C or below
Buffer composition20 mM Tris-HCl (pH 8.0) with 1mM DTT, 10% glycerol
Physical stateLiquid

The inclusion of DTT (a reducing agent) and glycerol (a cryoprotectant) in the storage buffer helps maintain protein stability by preventing oxidation of cysteine residues and protecting against freeze-thaw damage, respectively. Researchers should aliquot the protein upon receipt to minimize freeze-thaw cycles and maintain optimal activity.

How does CSTA contribute to intercellular adhesion mechanisms in the epidermis?

CSTA plays a crucial role in maintaining epidermal integrity through its involvement in desmosome-mediated intercellular adhesion . Desmosomes are specialized junctional complexes essential for cell-cell adhesion in epithelial tissues, particularly in tissues subjected to mechanical stress like the epidermis.

The contribution of CSTA to intercellular adhesion occurs through multiple mechanisms:

  • Protease inhibition: CSTA inhibits cysteine proteases that could otherwise degrade desmosomal component proteins, thereby preserving desmosomal integrity.

  • Structural stabilization: Evidence suggests CSTA may directly interact with desmosomal proteins, providing additional structural support beyond its protease inhibitory function.

  • Signaling regulation: CSTA may influence signaling pathways that control desmosome assembly, maintenance, and turnover.

Researchers investigating CSTA's role in epidermal biology should consider using three-dimensional skin equivalents or primary keratinocyte cultures to accurately model the complex intercellular interactions present in the epidermis.

What are the implications of CSTA in cancer research and signal transduction pathways?

CSTA has emerged as a significant protein in cancer research , with complex and sometimes contradictory implications depending on cancer type and stage. The relationship between CSTA and cancer involves several mechanisms:

  • Altered protease activity: Dysregulation of the balance between proteases and their inhibitors, including CSTA, can contribute to cancer progression by facilitating tissue invasion and metastasis.

  • Cell adhesion modulation: CSTA's role in maintaining desmosomal integrity affects cancer cell cohesion and potentially metastatic potential.

  • Signal transduction effects: CSTA is associated with signal transduction research areas , suggesting it may influence cellular signaling networks that regulate cell proliferation, survival, and migration.

Current research indicates that CSTA may act as either a tumor suppressor or promoter depending on the specific cancer context and molecular background. This dual nature makes CSTA an intriguing target for cancer research, requiring careful experimental design to elucidate its context-dependent functions.

How can researchers validate the bioactivity of recombinant CSTA in experimental models?

Validating the bioactivity of recombinant CSTA requires a multi-faceted approach combining biochemical assays with cellular models:

  • Enzymatic inhibition assays:

    • Measure inhibition of purified cysteine proteases (e.g., cathepsins B, H, L)

    • Determine inhibition constants (Ki values)

    • Compare activity with reference standards or native CSTA

  • Cellular functional assays:

    • Assess protection against protease-mediated cellular effects

    • Evaluate desmosomal integrity in keratinocyte models

    • Measure downstream effects on signal transduction pathways

  • Structural validation:

    • Circular dichroism spectroscopy to confirm proper protein folding

    • Size-exclusion chromatography to verify monomeric state

    • Thermal shift assays to assess protein stability

Validation MethodPurposeExpected Outcome for Active CSTA
Protease inhibition assayMeasure direct inhibitory activityConcentration-dependent inhibition of cysteine proteases
Thermal stability analysisAssess structural integrityWell-defined melting curve typical of properly folded protein
Cell adhesion assayEvaluate functional effect in keratinocytesEnhanced resistance to mechanical stress-induced cell dissociation
Western blotConfirm protein integritySingle band at expected molecular weight (~14 kDa for His-tagged form)

What experimental approaches are most effective for studying CSTA's protease inhibitor activity?

The most effective experimental approaches for studying CSTA's protease inhibitor activity combine biochemical characterization with cellular and physiological assays:

  • In vitro enzymatic assays:

    • Fluorogenic substrate assays with purified target proteases

    • Determination of inhibition kinetics (competitive vs. non-competitive)

    • Structural studies of CSTA-protease complexes

  • Cellular systems:

    • CSTA overexpression or knockdown/knockout models

    • Activity-based probes to visualize active proteases in situ

    • Measurement of protease-dependent cellular processes

  • Advanced techniques:

    • FRET-based sensors for real-time monitoring of protease activity

    • Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

    • Computational modeling of CSTA-protease interactions

When designing such experiments, researchers should carefully consider the physiological relevance of the experimental conditions, including pH, ionic strength, and the presence of potential cofactors that might influence CSTA activity in vivo.

How should researchers design human-in-the-loop experiments to study CSTA function?

Human-in-the-loop experimental designs can be valuable for studying CSTA function, particularly in contexts where human judgment and interpretation are essential. While traditional human-in-the-loop approaches have been described for driving simulations , similar principles can be applied to CSTA research:

  • Experimental setup considerations:

    • Design real-time monitoring systems for CSTA activity

    • Establish feedback mechanisms between computational predictions and researcher interventions

    • Create interfaces that allow researchers to adjust experimental parameters during ongoing experiments

  • Data integration approaches:

    • Combine automated data collection with expert human interpretation

    • Implement machine learning algorithms that incorporate researcher feedback

    • Develop visualization tools that highlight potential patterns for human evaluation

Such approaches are particularly valuable when studying complex biological systems where CSTA functions within networks of interacting proteins and cellular processes.

What techniques are most reliable for analyzing CSTA interactions with cis-regulatory elements?

Recent advancements in cis-element research provide valuable methodologies for studying potential interactions between CSTA and genomic regulatory regions. Based on approaches utilized in the FANTOM6 project , researchers can employ the following techniques:

  • Chromatin immunoprecipitation (ChIP):

    • Use anti-CSTA antibodies to identify potential DNA binding sites

    • Couple with next-generation sequencing (ChIP-seq) for genome-wide analysis

    • Integrate with databases like fanta.bio that contain cis-element information

  • CAGE (Cap Analysis Gene Expression) methodology:

    • Identify transcription start sites potentially regulated by CSTA

    • Map CSTA-associated regulatory networks

    • Correlate CSTA activity with promoter or enhancer function

  • Integrative bioinformatic approaches:

    • Combine CSTA binding data with transcriptomic analyses

    • Utilize databases that integrate cis-element data with other public resources

    • Apply computational models to predict regulatory interactions

The fanta.bio database contains information on 447,315 human and 288,877 mouse cis-element regions , providing a valuable resource for researchers investigating potential regulatory functions of CSTA beyond its canonical protease inhibitor role.

How can researchers effectively use CSTA in studies of epidermal differentiation and skin disorders?

For effective use of CSTA in studies of epidermal differentiation and skin disorders, researchers should employ a multi-scale approach:

  • Model systems selection:

    • 2D keratinocyte cultures for basic mechanistic studies

    • 3D organotypic skin models to recapitulate tissue architecture

    • Patient-derived samples to establish disease relevance

  • Analytical techniques:

    • Immunohistochemistry to map CSTA distribution in tissue sections

    • RNA-seq to identify CSTA-dependent gene expression changes

    • Proteomic analysis to determine effects on the desmosomal proteome

  • Functional assessments:

    • Barrier function measurements (e.g., transepithelial electrical resistance)

    • Cell-cell adhesion strength assays

    • Protease activity mapping in skin equivalents

When studying skin disorders, researchers should correlate CSTA expression patterns with specific disease phenotypes and consider genetic factors that might influence CSTA function or expression.

How can ChatGPT and AI tools be leveraged to evaluate CSTA research impact?

AI tools like ChatGPT can be valuable for assessing the broader impact of CSTA research in academic and societal contexts. Based on recent methodological developments in impact assessment , researchers studying CSTA can:

  • Conduct systematic literature analyses:

    • Use AI to identify and categorize CSTA-related publications

    • Track citation patterns and research trends over time

    • Map connections between CSTA research and other fields

  • Evaluate societal impact:

    • Analyze how CSTA research has influenced clinical practice

    • Assess translation of basic CSTA findings into therapeutic approaches

    • Identify potential public health implications of CSTA research

  • Guide research direction:

    • Identify knowledge gaps in current CSTA literature

    • Suggest promising research questions based on pattern recognition

    • Help formulate hypotheses by integrating disparate data sources

Recent research has shown that ChatGPT evaluations can correlate with expert assessments, with correlation values between 0.18 and 0.56 across different academic fields . While AI tools should not replace expert judgment, they can provide valuable support for impact assessment and research planning.

What are the recommended protocols for performing structure-function studies with CSTA?

Structure-function studies with CSTA require careful experimental design to correlate structural features with specific biological activities:

  • Mutagenesis approaches:

    • Site-directed mutagenesis of conserved residues

    • Domain swapping with related cystatins

    • Truncation analysis to identify functional regions

  • Structural analysis techniques:

    • X-ray crystallography of wild-type and mutant CSTA

    • NMR spectroscopy for solution structure determination

    • Molecular dynamics simulations to predict conformational changes

  • Functional validation methods:

    • Comparative protease inhibition assays of mutant variants

    • Cell-based assays measuring desmosomal integrity

    • Protein-protein interaction studies with known CSTA partners

CSTA RegionProposed FunctionExperimental Approach
N-terminal segmentInitial contact with target proteasesAlanine scanning mutagenesis with enzymatic activity assays
Conserved QXVXG motifCritical for protease bindingPoint mutations followed by binding affinity measurements
C-terminal regionPotential regulatory domainTruncation analysis with cellular localization studies
His-tag junctionPotential interference siteComparison of N-terminal vs. C-terminal tagged variants

When publishing structure-function findings, researchers should deposit structural data in appropriate databases and clearly describe the relationship between structural elements and functional outcomes.

What are the current gaps in CSTA research and promising future directions?

Despite significant progress in understanding CSTA biology, several knowledge gaps remain:

  • Mechanistic uncertainties:

    • The precise molecular mechanisms by which CSTA contributes to desmosomal integrity

    • The complete interactome of CSTA beyond its canonical protease targets

    • The role of post-translational modifications in regulating CSTA function

  • Pathological relevance:

    • The context-dependent roles of CSTA in different cancer types

    • The contribution of CSTA dysregulation to inflammatory skin disorders

    • Potential involvement in neurodegenerative diseases involving proteostasis imbalance

  • Therapeutic potential:

    • Whether CSTA or CSTA-derived peptides could serve as therapeutic agents

    • The druggability of the CSTA-protease interaction interface

    • Potential for gene therapy approaches in CSTA-deficient conditions

Future research directions should focus on integrating structural biology, systems biology, and translational approaches to develop a comprehensive understanding of CSTA function in health and disease. Particular attention should be paid to tissue-specific roles and context-dependent functions that might explain seemingly contradictory findings in different experimental systems.

How can researchers address the challenges of reproducibility in CSTA functional studies?

Ensuring reproducibility in CSTA research requires attention to several methodological considerations:

  • Standardization of materials and methods:

    • Use well-characterized recombinant proteins with documented purity and activity

    • Implement consistent storage and handling procedures

    • Establish standard assay conditions for protease inhibition measurements

  • Comprehensive reporting:

    • Provide detailed methods including buffer compositions and incubation times

    • Report protein concentrations, purity assessments, and activity validations

    • Include all negative and positive controls in published results

  • Validation across systems:

    • Confirm key findings in multiple cell types or model organisms

    • Employ complementary techniques to verify important results

    • Consider both tag-dependent and independent approaches

By addressing these factors, researchers can enhance the reliability and reproducibility of CSTA functional studies, ultimately accelerating progress in understanding this important protein's diverse biological roles.

Product Science Overview

Introduction

Cystatin A, also known as Stefin A, is a member of the cystatin superfamily of cysteine protease inhibitors. This protein plays a crucial role in inhibiting cysteine proteases, such as cathepsins B, H, and L, which are involved in various cellular processes including protein degradation, immune response, and apoptosis.

Structure and Expression

The recombinant human Cystatin A is typically produced in Escherichia coli (E. coli) expression systems. The protein is expressed as a single, non-glycosylated polypeptide chain containing 118 amino acids, with a molecular mass of approximately 13.1 kDa . To facilitate purification, a 6×His tag is fused to the N-terminus of the protein . This His tag allows for easy purification using nickel affinity chromatography.

Function and Mechanism

Cystatin A functions as a potent inhibitor of cysteine proteases. It forms tight, reversible complexes with its target enzymes, thereby preventing the proteolytic activity of these enzymes. This inhibition is crucial for maintaining cellular homeostasis and protecting cells from unwanted proteolysis. Cystatin A is particularly important in the skin, where it contributes to the formation and maintenance of the cornified cell envelope in keratinocytes .

Applications in Research

Recombinant Cystatin A is widely used in biochemical and biomedical research. Its ability to inhibit cysteine proteases makes it a valuable tool for studying protease function and regulation. Additionally, Cystatin A has been proposed as a potential prognostic and diagnostic marker for certain types of cancer . Researchers also use recombinant Cystatin A to investigate its role in various physiological and pathological processes.

Storage and Handling

For optimal stability, recombinant Cystatin A should be stored at -20°C to -80°C. After reconstitution, the protein solution is stable at -20°C for up to three months and at 2-8°C for up to one week. It is recommended to add a carrier protein or stabilizer, such as 0.1% BSA or 5% HSA, to prevent degradation during storage .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.